[Laparoscopic diagnosis and evaluation of danazol or gestrinone therapy for endometriosis in sterility]. 1988

T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
Department of Obstetrics and Gynecology, Kyushu University, Beppu.

In forty-six sterile women, endometriosis externa was diagnosed and classified laparoscopically. 21 patients were treated with Gestrinone 5mg-10mg/week and 25 patients were treated with Danazol 300mg-400mg/day for 6 months. The effects of these hormonal treatments were evaluated by second-look laparoscopy according to adhesion severity, number of blueberry spots and chocolate cyst size, as well as dysmenorrhea and other complaints. The results were as follows; 1) Dysmenorrhea was relieved in 60.0% of the Gestrinone-treated group and 45.5% of the Danazol group. 2) Adhesion was weakened or partially separated spontaneously in 66.7% of the Gestrinone group and 63.6% of the Danazol group. 3) Blueberry spots decreased in number or paled in 61.9% of the Gestrinone group and 75.0% of the Danazol group. 4) Chocolate cyst size became smaller in 60.0% of the Gestrinone group and 77.8% of the Danazol group. 5) Peritoneal fluid volume was not decreased after the hormonal treatments but the prostaglandin E2 concentration in peritoneal fluid was decreased (p less than 0.05) after Gestrinone therapy. 6) The patients complained of some side effects, liver function especially was disturbed in 48.0% of the Danazol group and 9.5% of the Gestrinone group. Hoarseness was complained of in 33.3% of the Gestrinone group and 12.0% of the Danazol group. 7) Finally, 23.8% of the Gestrinone group and 28.0% of the Danazol group conceived after the hormonal treatments.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D009651 Norpregnatrienes Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D005867 Gestrinone A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices. 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-,Dimetriose,Nemestran,R-2323,R2323,R 2323

Related Publications

T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
January 1992, Human pathology,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
October 1992, Ceskoslovenska gynekologie,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
May 1989, Fertility and sterility,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
January 1990, International journal of fertility,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
January 1990, Journal de gynecologie, obstetrique et biologie de la reproduction,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
March 1988, Ceskoslovenska gynekologie,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
January 1993, International journal of fertility and menopausal studies,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
May 1981, Fertility and sterility,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
September 2018, Pakistan journal of pharmaceutical sciences,
T Utsunomiya, and H Sumioki, and S Korenaga, and K Matsuoka, and M Korenga, and T Kadota
September 1980, Clinical obstetrics and gynecology,
Copied contents to your clipboard!